Found: 44
Select item for more details and to access through your institution.
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Distinct Characteristics and Changes in Liver Function of Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab for More Than 1 Year.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1231, doi. 10.4143/crt.2024.237
- By:
- Publication type:
- Article
Development of a Prediction Model for Delirium in Hospitalized Patients with Advanced Cancer.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1277, doi. 10.4143/crt.2023.1243
- By:
- Publication type:
- Article
A prospective study of remote delirium screening using the modified K-4AT for COVID-19 inpatients.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.976228
- By:
- Publication type:
- Article
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33267-z
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221148541
- By:
- Publication type:
- Article
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113266
- By:
- Publication type:
- Article
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
- By:
- Publication type:
- Article
SupporTive Care At Home Research (STAHR) for patients with advanced cancer: Protocol for a cluster non-randomized controlled trial.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0302011
- By:
- Publication type:
- Article
Changing treatment patterns in elderly patients with resectable colon cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 3, p. 265, doi. 10.1111/ajco.12042
- By:
- Publication type:
- Article
ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1291, doi. 10.4143/crt.2022.1450
- By:
- Publication type:
- Article
A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 2, p. 621, doi. 10.4143/crt.2021.483
- By:
- Publication type:
- Article
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1578, doi. 10.4143/crt.2018.671
- By:
- Publication type:
- Article
PTEN Methylation Dependent Sinonasal Mucosal Melanoma.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 853, doi. 10.4143/crt.2014.356
- By:
- Publication type:
- Article
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035983
- By:
- Publication type:
- Article
Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035983
- By:
- Publication type:
- Article
Delirium and its consequences in the specialized palliative care unit: Validation of the Korean version of Memorial Delirium Assessment Scale.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1335, doi. 10.3390/jcm13051335
- By:
- Publication type:
- Article
Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61627-w
- By:
- Publication type:
- Article
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5985, doi. 10.3390/cancers14235985
- By:
- Publication type:
- Article
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1747, doi. 10.3390/cancers14071747
- By:
- Publication type:
- Article
"The surprise questions" using variable time frames in hospitalized patients with advanced cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Is spirituality related to survival in advanced cancer inpatients in Korea?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1961, doi. 10.1111/liv.15935
- By:
- Publication type:
- Article
Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2544, doi. 10.1111/liv.14573
- By:
- Publication type:
- Article
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events.
- Published in:
- Liver International, 2020, v. 40, n. 9, p. 2263, doi. 10.1111/liv.14496
- By:
- Publication type:
- Article
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 89, doi. 10.1159/000531182
- By:
- Publication type:
- Article
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2731, doi. 10.1002/cam4.5161
- By:
- Publication type:
- Article
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 3, p. 345, doi. 10.3350/cmh.2023.0553
- By:
- Publication type:
- Article
Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 799, doi. 10.1007/s00280-014-2551-4
- By:
- Publication type:
- Article
Mid-upper Arm Circumference as an Indicator of Quality of Life of Patients with Advanced Cancer.
- Published in:
- Journal of Palliative Care, 2023, v. 38, n. 1, p. 24, doi. 10.1177/08258597221121321
- By:
- Publication type:
- Article
Prognostic Significance of Volume-Based FDG PET/CT Parameters in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation Therapy.
- Published in:
- Yonsei Medical Journal, 2014, v. 55, n. 6, p. 1498, doi. 10.3349/ymj.2014.55.6.1498
- By:
- Publication type:
- Article
Prognostic Significance of the Bone Marrow-to-Aorta Uptake Ratio on 2-Deoxy-2-[ 18 F]fluoro-d-glucose Positron Emission Tomography/Computed Tomography in Patients with Cholangiocarcinoma.
- Published in:
- Biomedicines, 2024, v. 12, n. 5, p. 944, doi. 10.3390/biomedicines12050944
- By:
- Publication type:
- Article
Performance of clinician prediction of survival in oncology outpatients with advanced cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267467
- By:
- Publication type:
- Article
Clinical findings, viral load, and outcomes of COVID-19: Comparison of patients with negative and positive initial chest computed tomography.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264711
- By:
- Publication type:
- Article
Pre‐screening of patient‐reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
- Published in:
- European Journal of Cancer Care, 2020, v. 29, n. 6, p. 1, doi. 10.1111/ecc.13305
- By:
- Publication type:
- Article
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198544
- By:
- Publication type:
- Article
Prognostic Impact of Visceral Adipose Tissue Imaging Parameters in Patients with Cholangiocarcinoma after Surgical Resection.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3939, doi. 10.3390/ijms25073939
- By:
- Publication type:
- Article
Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56675-1
- By:
- Publication type:
- Article
High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 6, p. 935, doi. 10.7150/jca.81384
- By:
- Publication type:
- Article
Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-394
- By:
- Publication type:
- Article
Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article